To_TO determine_VB whether_IN the_DT defect_NN in_IN the_DT patient_NN T_NN lymphocytes_NNS involved_VBD a_DT trans-acting_JJ factor_NN common_JJ to_TO the_DT affected_VBN lymphokine_NN genes_NNS ,_, we_PRP examined_VBD the_DT ability_NN of_IN nuclear_JJ factors_NNS from_IN the_DT patient_NN T_NN lymphocytes_NNS to_TO bind_VB response_NN elements_NNS present_JJ in_IN the_DT regulatory_JJ region_NN of_IN IL2_NN ._.
